Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
05/1996
05/30/1996WO1996016164A1 Viral preparations, immunogens, and vaccines
05/30/1996WO1996016087A1 G-protein coupled receptor
05/30/1996WO1996016075A1 Antibiotic cryptdin peptides and methods of their use
05/30/1996WO1996015799A1 Methods for the prevention or treatment of vascular hemorrhaging and alzheimer's disease
05/30/1996WO1996015797A1 Pharmaceutical compositions comprising nitric oxide-releasing biopolymers
05/30/1996WO1996015780A1 Compositions and methods for preventing and treating allograft rejection
05/30/1996WO1996015779A1 Unique associated kaposi's sarcoma virus sequences and uses thereof
05/30/1996WO1996012807A3 Hepatitis e virus antigens and uses therefor
05/30/1996DE19541284A1 Verfahren zur Immunmodulation Methods for immunomodulation
05/30/1996CA2205130A1 Immunogens for stimulating mucosal immunity
05/30/1996CA2204438A1 Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof
05/30/1996CA2204252A1 Expression of the bovine parainfluenza virus type 3 hemagglutinin/neuraminidase (hn) glycoprotein in two heterologous systems
05/29/1996EP0713915A1 Hog cholera virus vaccine and diagnostic
05/29/1996EP0713530A1 High level expression, purification and refolding of the neisseria meningitidis outer membrane group b porin proteins
05/29/1996EP0713529A1 NEW GROWTH/DIFFERENTIATION FACTOR OF THE TGF-$g(b) FAMILY
05/29/1996EP0713496A1 Fibrin-targeted inhibitors of thrombin
05/29/1996EP0713398A1 POLYPEPTIDES CODED BY EXON v5 OF THE CD44 GENE AS TARGETS FOR IMMUNOTHERAPY AND IMMUNOSCINTIGRAPHY OF TUMOURS
05/29/1996EP0713397A1 Vaccine containing live virus for therapy of viral diseases and malignancies
05/29/1996EP0713388A1 A method for high loading of vesicles with biopolymeric substances
05/29/1996EP0469065B1 Recombinant antibody-toxin fusion protein
05/29/1996CN1123185A Immune couplet
05/29/1996CN1123182A Preparation method for abalone artificial immune material
05/28/1996US5521297 Nucleic acids encoding human metabotropic glutamate receptors
05/28/1996US5521285 CTAA 28A32, the antigen recognized by MCA 28A32
05/28/1996US5521084 Bovine heat shock promoter and uses thereof
05/28/1996US5521083 Large granular lymphocyte leukemia associated virus
05/28/1996US5521082 Solvent extraction, precipitation, gel filtration, ion exchanging, vaccines
05/28/1996US5521072 Vaccines
05/28/1996CA2078996C A bifunctional dtpa-type ligand
05/23/1996WO1996015451A1 Methods of monitoring immune responses to hiv during treatment of secondary infections
05/23/1996WO1996015273A1 Method for identifying protective antigens for eliciting neutralizing antibodies
05/23/1996WO1996015249A1 High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications
05/23/1996WO1996015247A1 Purified papillomavirus proteins
05/23/1996WO1996015241A2 A polynucleotide tuberculosis vaccine
05/23/1996WO1996015238A1 Targeted t lymphocytes
05/23/1996WO1996015237A2 Delivery system
05/23/1996WO1996015232A1 Novel replication process
05/23/1996WO1996015231A2 Method for producing biologicals in protein-free culture
05/23/1996WO1996015153A1 Human antibodies to t-cell receptor peptides and methods for their preparation
05/23/1996WO1996015141A1 Cholesteryl ester transfer protein inhibitor peptides and prophylactic and therapeutic anti-arteriosclerosis agents
05/23/1996WO1996014879A1 Methods for use of novel lyoprotectants and instant kit formulations for radiopharmaceuticals using the same
05/23/1996WO1996014876A1 Yeast-based delivery vehicles
05/23/1996WO1996014874A1 Method for gene therapy involving suppression of an immune response
05/23/1996WO1996014871A1 Immunogenic compositions
05/23/1996WO1996014866A1 Non-infective vaccines
05/23/1996WO1996014860A1 Process for identifying para cation channel modulators
05/23/1996WO1996014855A1 Method for inducing humoral and cellular immune responses utilizing intracellular delivery of peptide-coated microparticles
05/23/1996WO1996014853A1 Intrathymic stem cell implantation
05/23/1996WO1996014836A1 Method and apparatus for gene therapy
05/23/1996WO1996014831A1 Adjuvant for a vaccine composition
05/23/1996WO1996012020A3 Hemoglobin receptors from neisseriae
05/23/1996WO1996010580A3 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines
05/23/1996WO1995034308A3 Adjuvant compositions comprising a mineral salt and another immunostimulating compound
05/23/1996CA2205360A1 Methods for use of novel lyoprotectants and instant kit formulations for radiopharmaceuticals using the same
05/23/1996CA2205138A1 Human antibodies to t-cell receptor peptides and methods for their preparation
05/23/1996CA2205083A1 Immunogenic compositions
05/23/1996CA2205029A1 Delivery system
05/23/1996CA2204914A1 High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications
05/23/1996CA2204863A1 Method for identifying protective antigens for eliciting neutralizing antibodies
05/23/1996CA2203934A1 Targeted t lymphocytes
05/22/1996EP0712926A2 Fish pancreatic disease virus
05/22/1996EP0712863A1 Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (EGF-R); diagnostic and therapeutic use
05/22/1996EP0712442A1 Vaccine compositions
05/22/1996EP0712414A1 Recombinant vector containing a lipoprotein gene sequence for expressing nucleotide sequences
05/22/1996EP0712313A1 Pro-cytotoxic drug conjugates for anticancer therapy
05/22/1996EP0712312A1 Suppression of inhibitors
05/22/1996EP0565548B1 Two-phase system for the production and presentation of foreign antigens in hybrid live vaccines
05/22/1996EP0454735B1 Vaccine composition
05/21/1996US5519120 Urokinase-type plasminogen activator receptor antibodies
05/21/1996US5519117 Polypeptide sequences as anticarcinogenic agents
05/21/1996US5519114 Retroviral superantigens, superantigen peptides, and methods of use
05/21/1996US5518916 Cloned Babesia DNA
05/21/1996US5518725 Vaccine compositions and method for induction of mucosal immune response via systemic vaccination
05/21/1996US5518724 Infectious bursal disease virus
05/21/1996US5518723 Vaccines containing antibodies and epitopes
05/17/1996WO1996014418A1 Respiratory syncytial virus protein g expressed on bacterial membrane
05/17/1996WO1996014416A1 Method for enhancing the immunogenicity of an immunogenic compound or hapten, and use thereof for preparing vaccines
05/17/1996WO1996014415A1 Carrier protein having an adjuvant effect, immunogenic complex containing same, preparation method therefor, nucleotide sequence and vaccine
05/17/1996WO1996014409A1 Production of recombinant peptides as natural hydrophobic peptide analogues
05/17/1996WO1996014407A1 Recombinant alternaria alternata allergens
05/17/1996WO1996014401A1 Transgenic organisms and their uses
05/17/1996WO1996014399A1 Porcine striatal cells and their use in treatment of neurological deficits due to neurodegenerative disease
05/17/1996WO1996014398A1 Porcine mesencephalic cells and their use in treatment of neurological deficits due to neurodegenerative diseases
05/17/1996WO1996014397A1 Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases
05/17/1996WO1996014393A1 H. pylori fermentation process
05/17/1996WO1996014340A1 Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for the determination thereof
05/17/1996WO1996014339A1 Antibodies
05/17/1996WO1996014333A1 Peptides for anti-allergy treatment
05/17/1996WO1996014111A1 Golf club receptacle
05/17/1996WO1996014088A1 Attenuated canine parvovirus vaccine
05/17/1996WO1996014087A1 Specific immunotherapy of cancer using a live recombinant bacterial vaccine vector
05/17/1996WO1996014086A1 Combined meningitis vaccine
05/17/1996WO1996014074A1 Methods and devices for immunizing a host to tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
05/17/1996WO1996011279A3 Enhanced immune response by introduction of cytokine gene and/or costimulatory molecule b7 gene in a recombinant virus expressing system
05/17/1996WO1996010639A3 The taga gene and methods for detecting predisposition to peptic ulceration and gastric carcinoma
05/17/1996WO1996010419A3 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule
05/17/1996CA2689871A1 Combined meningitis vaccine
05/17/1996CA2320579A1 Peripheral nervous system specific sodium channels, dna encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
05/17/1996CA2204619A1 Method for enhancing the immunogenicity of an immunogenic compound or hapten, and use thereof for preparing vaccines
05/17/1996CA2204618A1 Respiratory syncytial virus protein g expressed on bacterial membrane
1 ... 1641 1642 1643 1644 1645 1646 1647 1648 1649 1650 1651 1652 1653 1654 1655 1656 1657 1658 1659 1660 1661 ... 1823